Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inbiotech is a Bulgarian pharmaceutical company founded in 1991 that specializes in the development, manufacturing, and marketing of generic pharmaceutical products. The company offers a diverse portfolio of medicines across several therapeutic areas, including neurology, cardiology, pulmonology, gastroenterology, and urology. Inbiotech focuses on providing high-quality, affordable generic alternatives to established brands, serving both the Bulgarian market and international markets. Their operations include research and development of generic formulations and the commercialization of finished dosage forms. The company is recognized for its commitment to international quality standards and its role in improving access to essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InBiotech.